Patents by Inventor Andrew M. Stern

Andrew M. Stern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210383894
    Abstract: A method of generating a plurality of spatially co-registered data elements, each spatially co-registered data element being associated with and generated from a pair of co-registered tissue sections obtained from adjacent positions of a core taken from a tissue sample and including an image data section and a genomic data section. The method includes, for each pair of co-registered tissue sections: (i) obtaining and storing as part of a data element a plurality of multi to hyperplexed images from the imaging data section of the co-registered tissue section, (ii) generating and storing as part of the data element image data from the plurality of multi to hyperplexed images, and (iii) generating and storing as part of the data element genomic data from the genomic data section of the associated co-registered tissue section.
    Type: Application
    Filed: August 21, 2019
    Publication date: December 9, 2021
    Applicant: UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: SRINIVAS C. CHENNUBHOTLA, ALBERT H. GOUGH, ANDREW M. STERN, MICHAEL J. BECICH, DOUGLASS L. TAYLOR
  • Patent number: 8933071
    Abstract: Disclosed are methods for inducing polyploidization of megakaryocyte cells and for promoting differentiation of megakaryocyte cells into platelet-producing cells. The methods may be utilized for treating blood and bone marrow diseases and disorders in a subject in need thereof and for identifying agents for treating blood and bone marrow diseases and disorders.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: January 13, 2015
    Assignees: Northwestern University, Massachusetts Institute of Technology
    Inventors: John D. Crispino, Qiang Wen, Zan Huang, Andrew M. Stern, Robert J. Gould
  • Publication number: 20130338092
    Abstract: This invention relates to high-throughput, semi-automated methods for identifying compounds that are effective in targeting leukemia stem cells, as well as compounds identified by those methods and uses thereof for treating leukemia.
    Type: Application
    Filed: August 16, 2013
    Publication date: December 19, 2013
    Inventors: Kimberly Hartwell, Malcolm A.S. Moore, David T. Scadden, Stuart L. Schreiber, Todd R. Golub, Benito Munoz, Benjamin L. Ebert, Andrew M. Stern, Peter G. Miller, D. Gary Gilliland, Anne Van Dyk Carpenter, David J. Logan, Joseph Negri, Nicola Tolliday, Alykhan Shamji, Siddhartha Mukherjee, Alison Stewart
  • Publication number: 20130084561
    Abstract: The invention provides compositions and methods for the detection of biological targets, (e.g. nucleic acids and proteins) by nucleic acid templated chemistry, for example, by generating fluorescent, chemiluminescent and/or chromophoric signals.
    Type: Application
    Filed: May 9, 2012
    Publication date: April 4, 2013
    Inventors: James M. Coull, Andrew M. Stern, Lawrence A. Haff, Barbara S. Fox, Yumei Huang
  • Publication number: 20100159455
    Abstract: The invention provides compositions and methods, e.g., assay technologies and their use in biodetection and diagnostics. More particularly, the invention provides compositions and methods based on nucleic acid-templated chemistry in biodetection and profiling of receptors (and their families) and proteins (and their families), and the use of same in diagnostics.
    Type: Application
    Filed: September 18, 2007
    Publication date: June 24, 2010
    Inventors: Tanya Landsman, David J. Livingston, Richard A. Martinelli, Yumei Huang, Benjamin Adam Seigal, Dingxue Yan, James M. Coull, Andrew M. Stern
  • Publication number: 20100120750
    Abstract: Disclosed are methods for inducing polyploidization of megakaryocyte cells and for promoting differentiation of megakaryocyte cells into platelet-producing cells. The methods may be utilized for treating blood and bone marrow diseases and disorders in a subject in need thereof and for identifying agents for treating blood and bone marrow diseases and disorders.
    Type: Application
    Filed: November 6, 2009
    Publication date: May 13, 2010
    Applicant: Northwestern University
    Inventors: John D. Crispino, Qiang Wen, Zan Huang, Andrew M. Stern, Robert J. Gould
  • Publication number: 20090163371
    Abstract: The invention provides methods for compound and lead generation and discovery. In particular, the present invention provides a method for generating compounds and for selecting compounds that bind to a target. The present invention provides a way by which anchors (e.g., weak binders) and anchor-scaffold conjugates can be evolved into new generations of compounds having improved target binding and other desired pharmaceutical properties through control of both synthetic input and selection criteria.
    Type: Application
    Filed: May 31, 2006
    Publication date: June 25, 2009
    Inventors: Andrew M. Stern, Scott L. Harbeson, Edward M. Driggers, Kerry L. Spear
  • Patent number: 5188830
    Abstract: Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
    Type: Grant
    Filed: April 2, 1990
    Date of Patent: February 23, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Atkinson, David A. Claremon, John J. Baldwin, Paul A. Friedman, David C. Remy, Andrew M. Stern
  • Patent number: 5185149
    Abstract: Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
    Type: Grant
    Filed: April 2, 1990
    Date of Patent: February 9, 1993
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Paul A. Friedman, Andrew M. Stern
  • Patent number: 4968494
    Abstract: Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
    Type: Grant
    Filed: April 10, 1990
    Date of Patent: November 6, 1990
    Assignee: Merck & Co., Inc.
    Inventors: David A. Claremon, Paul A. Friedman, David C. Remy, Andrew M. Stern